[go: up one dir, main page]

IT1275434B - Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante - Google Patents

Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante

Info

Publication number
IT1275434B
IT1275434B ITMI951021A ITMI951021A IT1275434B IT 1275434 B IT1275434 B IT 1275434B IT MI951021 A ITMI951021 A IT MI951021A IT MI951021 A ITMI951021 A IT MI951021A IT 1275434 B IT1275434 B IT 1275434B
Authority
IT
Italy
Prior art keywords
pharmaceutical
pct
antioxidant activity
dietary compositions
sec
Prior art date
Application number
ITMI951021A
Other languages
English (en)
Inventor
Roberto Bianchi
Original Assignee
Farmila Farma Milano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmila Farma Milano filed Critical Farmila Farma Milano
Publication of ITMI951021A0 publication Critical patent/ITMI951021A0/it
Priority to ITMI951021A priority Critical patent/IT1275434B/it
Priority to AU58974/96A priority patent/AU697990B2/en
Priority to PCT/EP1996/002079 priority patent/WO1996036348A1/en
Priority to AT96916082T priority patent/ATE204479T1/de
Priority to PT96916082T priority patent/PT825871E/pt
Priority to US08/952,437 priority patent/US5866537A/en
Priority to DE69614681T priority patent/DE69614681T2/de
Priority to JP53455596A priority patent/JP4850986B2/ja
Priority to EP96916082A priority patent/EP0825871B1/en
Priority to CA002221455A priority patent/CA2221455C/en
Priority to ES96916082T priority patent/ES2159737T3/es
Publication of ITMI951021A1 publication Critical patent/ITMI951021A1/it
Application granted granted Critical
Publication of IT1275434B publication Critical patent/IT1275434B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
ITMI951021A 1995-05-19 1995-05-19 Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante IT1275434B (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ITMI951021A IT1275434B (it) 1995-05-19 1995-05-19 Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
DE69614681T DE69614681T2 (de) 1995-05-19 1996-05-15 Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten
PCT/EP1996/002079 WO1996036348A1 (en) 1995-05-19 1996-05-15 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
AT96916082T ATE204479T1 (de) 1995-05-19 1996-05-15 Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten
PT96916082T PT825871E (pt) 1995-05-19 1996-05-15 Composicoes farmaceuticas e/ou dieteticas com actividade anti-oxidante contendo carnosina ou derivados e amino acidos ramificados
US08/952,437 US5866537A (en) 1995-05-19 1996-05-15 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
AU58974/96A AU697990B2 (en) 1995-05-19 1996-05-15 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
JP53455596A JP4850986B2 (ja) 1995-05-19 1996-05-15 カルノシンあるいはその誘導体および分枝アミノ酸を含む抗酸化活性を有する医薬組成物および／または栄養組成物
EP96916082A EP0825871B1 (en) 1995-05-19 1996-05-15 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
CA002221455A CA2221455C (en) 1995-05-19 1996-05-15 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
ES96916082T ES2159737T3 (es) 1995-05-19 1996-05-15 Composiciones farmaceuticas y/o dieteticas con actividad antioxidante que contienen carnosina o derivados y aminoacidos ramificados.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI951021A IT1275434B (it) 1995-05-19 1995-05-19 Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante

Publications (3)

Publication Number Publication Date
ITMI951021A0 ITMI951021A0 (it) 1995-05-19
ITMI951021A1 ITMI951021A1 (it) 1996-11-19
IT1275434B true IT1275434B (it) 1997-08-07

Family

ID=11371632

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI951021A IT1275434B (it) 1995-05-19 1995-05-19 Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante

Country Status (11)

Country Link
US (1) US5866537A (it)
EP (1) EP0825871B1 (it)
JP (1) JP4850986B2 (it)
AT (1) ATE204479T1 (it)
AU (1) AU697990B2 (it)
CA (1) CA2221455C (it)
DE (1) DE69614681T2 (it)
ES (1) ES2159737T3 (it)
IT (1) IT1275434B (it)
PT (1) PT825871E (it)
WO (1) WO1996036348A1 (it)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69535104T2 (de) * 1994-11-08 2007-02-08 Avicena Group, Inc., Cambridge Verwendung von kreatin oder kreatinanologen zur behandlung von huntington chorea, morbus parkinson und amyotrophen lateralsklerose
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US8128955B2 (en) 1996-05-31 2012-03-06 The Original Creatine Patent Company Food compositions containing creatine
US7150880B2 (en) 1996-05-31 2006-12-19 The Original Creatine Patent Co. Ltd. Compositions containing creatine and creatinine and a methyl xanthine
US6524611B2 (en) 1996-05-31 2003-02-25 The Howard Foundation Compositions containing creatine and creatinine
GB9611356D0 (en) * 1996-05-31 1996-08-07 Howard Alan N Improvements in or relating to compositions containing Creatine, and other ergogenic compounds
US6168802B1 (en) 1996-05-31 2001-01-02 The Howard Foundation Compositions containing creatine and aloe vera extract
US6274161B1 (en) 1996-05-31 2001-08-14 The Howard Foundation Compositions containing creatine in suspension
DE19649891C2 (de) * 1996-12-02 1998-12-10 Mk Produktkontor Gmbh Verwendung von antioxidativen Zusammensetzungen mit Süßmolkekonzentrat
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
RU2141483C1 (ru) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
DE19806890A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Kosmetische und dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Antioxidans sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
US20060128671A1 (en) * 1998-04-02 2006-06-15 The General Hospital Corporation Compositions containing a combination of a creatine compound and a second agent
EP1065931A4 (en) * 1998-04-02 2006-10-11 Avicena Group Inc COMPOSITIONS CONTAINING CREATINE COMBINED WITH A SECOND AGENT
IT1299191B1 (it) * 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
CA2338638C (en) * 1998-07-30 2009-03-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
WO2000007607A1 (en) * 1998-08-04 2000-02-17 Kosbab, John, V. Nutrient and therapeutic compositions for the treatment of cancer
IT1302863B1 (it) * 1998-11-13 2000-10-10 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante e preventiva di alterazionitrombotiche e aterosclerotiche comprendente una carnitina ed un
NO993678L (no) * 1999-07-28 2001-01-29 Norsk Hydro As Fôr for salmonider
US6294579B1 (en) 1999-10-11 2001-09-25 Joseph W. Carnazzo Method for improving delivery of tyrosine supplementation
AUPQ515000A0 (en) * 2000-01-19 2000-02-10 Grigg, Geoffrey Walter Treatment of uv induced immunosuppression
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
US6476010B2 (en) 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
IT1317008B1 (it) * 2000-04-04 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare energizzante sulla muscolatura scheletrica eprotettivo sull'apparato cardiovascolare.
US8252309B2 (en) * 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
KR100868592B1 (ko) * 2000-09-14 2008-11-13 보드 오브 리젠츠 오브 디 유니버시티 오브 네브라스카 크레아틴 에스터 전영양소 화합물과 제형
US20030212136A1 (en) 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
DE60212015T2 (de) * 2001-03-16 2006-11-02 Suntory Ltd. Autonomsystem kontrollagentien und gesundheitsgetränke und -nahrungsmittel
JP2005528424A (ja) * 2002-06-04 2005-09-22 アビセナ グループ インコーポレイティッド 脳内エネルギー代謝を調節することによって認知機能障害を治療する方法
US6793193B2 (en) * 2002-08-20 2004-09-21 Dart Industries Inc. Adjustable mold for forming shaped food
WO2004028536A1 (en) * 2002-09-30 2004-04-08 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
US20060116328A1 (en) * 2003-01-20 2006-06-01 Babizhayev Mark A Combined use of carnosinase inhibitor with l-carnosines and composition
EP2233127B1 (de) 2004-03-17 2020-05-27 Stada Arzneimittel Ag Verwendung von Antioxidantien zur Herstellung einer pharmazeutischen oder kosmetischen Zusammensetzung zum Schutz der Haut gegen Schädigung durch Infrarot-Strahlung
WO2005120543A1 (en) 2004-06-08 2005-12-22 Flamma, S.P.A. Compositions containing d-carnosine
JP2006052186A (ja) * 2004-08-16 2006-02-23 Toagosei Co Ltd 新規ジヒドロフェルラ酸縮合物
WO2006026304A1 (en) * 2004-08-25 2006-03-09 Ivax Corporation Cardioprotective formulations and uses thereof
EP1883406B1 (en) 2005-05-23 2016-07-06 Natural Alternatives International, Inc. Compositions and methods for the sustained release of beta-alanine
US20070292403A1 (en) * 2006-05-11 2007-12-20 Avicena Group, Inc. Methods of treating a neurological disorder with creatine monohydrate
US9421262B2 (en) * 2009-10-28 2016-08-23 Biomed Research & Technologies, Inc. Compositions and methods for treating dermatological conditions
WO2011078204A1 (ja) * 2009-12-24 2011-06-30 浜理薬品工業株式会社 高脂血症の予防または治療剤、および抗疲労剤
BR112013016021A2 (pt) * 2010-12-21 2018-12-11 Nestec Sa métodos e composições adequadas para gerenciar glicemia em animais
US9233099B2 (en) 2012-01-11 2016-01-12 University Of Cincinnati Methods of treating cognitive dysfunction by modulating brain energy metabolism
JP2014114244A (ja) * 2012-12-11 2014-06-26 Ito En Ltd 抗疲労剤組成物
JP6401028B2 (ja) * 2014-11-27 2018-10-03 Ｓｈｉｏｄａライフサイエンス株式会社 鯨筋肉抽出物からなる中長期記憶障害予防改善剤
JP2016130229A (ja) * 2015-01-15 2016-07-21 有限会社アント アミノ酸溶解物の製造方法および該製造方法により製造したアミノ酸溶解物
FR3056381B1 (fr) * 2016-09-26 2019-11-15 Futur Optimal Composition comprenant de la carnosine
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
WO2019036471A1 (en) 2017-08-14 2019-02-21 Axcella Health Inc. AMINO ACIDS BRANCHED FOR THE TREATMENT OF LIVER DISEASE
JP2021527670A (ja) 2018-06-20 2021-10-14 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． 筋肉中の脂肪浸潤の治療のための組成物及び方法
US20220218640A1 (en) * 2021-01-14 2022-07-14 Rob Dickerman Amino acid delivery system
JP2023156812A (ja) * 2022-04-13 2023-10-25 サントリーホールディングス株式会社 組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1240336B (it) * 1990-03-21 1993-12-07 Setra Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica

Also Published As

Publication number Publication date
DE69614681T2 (de) 2002-07-04
JP4850986B2 (ja) 2012-01-11
ITMI951021A0 (it) 1995-05-19
AU5897496A (en) 1996-11-29
WO1996036348A1 (en) 1996-11-21
JPH11505540A (ja) 1999-05-21
EP0825871B1 (en) 2001-08-22
ATE204479T1 (de) 2001-09-15
PT825871E (pt) 2001-12-28
EP0825871A1 (en) 1998-03-04
AU697990B2 (en) 1998-10-22
ITMI951021A1 (it) 1996-11-19
US5866537A (en) 1999-02-02
DE69614681D1 (de) 2001-09-27
CA2221455A1 (en) 1996-11-21
CA2221455C (en) 2008-07-08
ES2159737T3 (es) 2001-10-16

Similar Documents

Publication Publication Date Title
IT1275434B (it) Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
FR2688422B1 (it)
EP1166767A3 (en) Skin care product containing hydroxyproline or N-acylated hydroxyproline derivatives
CA2341973A1 (en) Antioxidant composition comprising acetyl l-carnitine and .alpha.-lipoic acid
IL124674A0 (en) Piperazine derivatives pharmaceutical compositions containing the same and use thereof
CA2163706A1 (en) Amino Acid Derivatives of Paclitaxel
AU1380199A (en) Gelatine compositions
GB2288732B (en) Pharmaceutical compositions
IT1312377B1 (it) Composizioni a base di acido tiottico, cisteina e/o n-acetil cisteinada utilizzarsi in preparazioni farmaceutiche, dietetiche e cosmetiche
BR9609413A (pt) Formulações de dieta e farmacêuticas para a profilaxia e o tratamento de distúrbios gastrintestinais
GEP20063818B (en) Orodispersible pharmaceutical composition comprising agomelatine
ES2191174T3 (es) (-)hidroxicitrato de magnesio, procedimiento de preparacion, aplicaciones y composiciones principalmente farmaceuticas que lo contienen.
ATE271392T1 (de) Lipoproteinkomplexe und zusammensetzungen, die diese enthalten
HUP9900085A3 (en) Azine derivatives, of amino acids and pharmaceutical compositions containing them
RS20070379A (en) Pharmaceutical compositions of tizoxanide and nitazoxide
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
DE69525649D1 (de) Lamotrigin haltiges arzneimittel
CA2215470A1 (fr) Composes biaryles heterocycliques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
NZ333966A (en) Use of 1-nonen-3-one as a flavouring agent
BR9809368A (pt) Composições sólidas adequadas para administração oral compreendendo l-carnitina ou fumarato de magnésio de alcanoil-l-carnitina.
GB2379855A (en) Dietary regime for companion animals
BR0211245A (pt) Alimento contendo proteìna compreendendo uma enzima de ligação cruzada e um hidrocolóide
GEP20063820B (en) Orodispersible pharmaceutical composition comprising ivabradine
GEP20063821B (en) Orodispersible pharmaceutical composition comprising perindopril
CA2217513A1 (en) Pharmaceutical agents for the treatment of alzheimer's disease

Legal Events

Date Code Title Description
0001 Granted